RxDoctor Payments Data

Samuel Hammer-Nahman

Podiatrist · San Diego, CANPI 1962897017

Payments from drug & device makers

$2,825in general payments, 2019–2025

Across 36 payments — averaging $78.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Integra Lifesciences Corporation$748
  • Paragon 28, Inc.$626
  • Sportstek Medical, Inc$525
  • Stryker$442
  • Arthrex$189
  • Linvatec Corporation$136
  • plus $159 from 6 others

What the payments were for

  • Travel & lodging$44916%
  • Food & beverage$1,10339%
  • Education$52519%
  • Other$74826%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Integra Lifesciences Corporation3$748
Paragon 28, Inc.3$626
Sportstek Medical, Inc1$525
Stryker17$442
Arthrex4$189
Linvatec Corporation1$136
Treace Medical Concepts, Inc.1$52
Smith+Nephew2$31
Orthofix Medical, Inc.1$28
Elevate Surgical Co1$17
Johnson & Johnson1$16
Carbofix Orthopedics Inc1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,825 in reported general payments places this provider in the 70th percentile of 721 podiatrist providers in California.

See all podiatrist providers in California

Medicare billing

Part B allowed, 2024
$62,534
Medicare patients
239
Services billed
721

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cephalexin21$278
Mupirocin15$152
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen15$137
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav11$135
Gabapentin11$57

Paid to pharmacies, not to this prescriber.

Other podiatrist in San Diego

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →